Search

Two new crystalline polymorphs of the widely used antifungal drug griseofulvin (phases II and III), which originate from the crystallization of the melt, have been detected recently. The crystal structure of phase II of griseofulvin {systematic name: (2S,6′R)‐7‐chloro‐2′,4,6‐trimethoxy‐6′‐methyl‐3H,4′H‐spiro[1‐benzofuran‐2,1′‐cyclohex‐2‐ene]‐3,4′‐dione}, C17H17ClO6, has been solved by powder X‐ray diffraction (PXRD). The PXRD pattern of this new phase was recorded at room temperature using synchrotron radiation. The starting structural model was generated by a Monte Carlo simulated annealing method. The final structure was obtained through Rietveld refinement with soft restraints for interatomic bond lengths and angles, except for the aromatic ring, where a rigid‐body constraint was applied. The symmetry is orthorhombic (space group P212121) and the asymmetric unit contains two molecules. [ABSTRACT FROM AUTHOR]

Annealing of the quenched ibuprofen at 258 K yielded a new crystalline form, called phase II. Powder X-ray diffraction patterns of this phase II were recorded with a laboratory diffractometer equipped with an INEL G3000 goniometer and a curved position-sensitive detector CPS120. The starting structural model was found by a Monte-Carlo simulated annealing method. The final structure was obtained through Rietveld refinements with rigid-body constraints for the phenyl group and soft restraints on the other interatomic bond lengths and bond angles. The cell volume is 5% larger than that of the conventional phase I at 258 K. It is also shown that the orientation of the propanoic acid group is drastically changed with respect to phase I, leading to strong modifications of the orientation of the O-H∙∙∙0 hydrogen bonds with respect to the chains of dimers. These structural considerations could explain the metastable character of this phase II. [ABSTRACT FROM AUTHOR]